Table I.

Patient Characteristics

Patient Characteristics	Included patients (n=178)
Age	56.9 (33.6 – 89.2)
Gender (% Male)	138 (77.5%)
Race
Caucasian	41 (23.0%)
Black	72 (40.5%)
Hispanic	50 (28.1%)
Asian	15 (8.4%)
Etiology
Hepatitis C	129 (72.5%)
Hepatitis B	13 (7.3%)
Alcohol	20 (11.2%)
NAFLD	12 (6.7%)
Other	4 (2.3%)
Insurance status
Medicare	52 (29.2%)
Medicaid	26 (14.6%)
Private Insurance	13 (7.3%)
None	87 (48.9%)
Alcohol (% active)	42 (23.6%)
Presence of ascites	79 (44.4%)
Presence of hepatic encephalopathy	37 (20.8%)
Presence of any hepatic decompensation	85 (47.8%)
Platelet count * 1000/mm3	124.5 (6 – 542)
AST (U/L)	88 (17 – 968)
ALT (U/L)	48 (9 – 283)
Bilirubin (mg/dL)	1.4 (0.2 – 22.4)
Albumin (g/dL)	3.2 (1.6 – 4.5)
INR	1.2 (.9 – 3.3)
Number of primary care clinic visits prior to HCC diagnosis	6 (0 – 39)
Receipt of hepatology care prior to HCC diagnosis	66 (37.1%)
Functional status (% ECOG 0–1)	156 (87.6%)
Child-Pugh score	7 (5 – 15)
Child-Pugh classification
Child A	70 (39.3%)
Child B	64 (36.0%)
Child C	44 (24.7%)

All data are expressed as median (range) unless otherwise specified

ALT – alanine aminotransferase; AST – aspartate aminotransferase; ECOG – Eastern Cooperative Oncology Group; HCC – hepatocellular carcinoma; INR – international normalized ratio; NAFLD – nonalcoholic fatty liver disease